Ozempic Cost Explained: Monthly, Yearly, and How to Save

Ozempic at a glance:

• Drug class: GLP-1 receptor agonist
• Manufacturer: Novo Nordisk
• FDA approved: 2017
• Route: subcutaneous injection (multi-dose pen)
• Typical frequency: once weekly
• Half-life: approximately 7 days (allows once-weekly dosing)
• Cash price (US): $950-$1,000/month without insurance
• Receptor target: GLP-1 receptor

Let's get specific about Ozempic pricing in 2026. The cash price is roughly $950-$1,000/month without insurance. What you actually pay depends on insurance status, manufacturer programs, and whether you use a discount card.

Ozempic Cash Price

Without insurance, Ozempic runs $950-$1,000/month without insurance in the US market.

That number is the starting point — what you actually pay depends on:

• Insurance status (commercial, Medicare, Medicaid, uninsured)
• Manufacturer savings programs (where applicable)
• Discount cards (GoodRx, Cost Plus Drug, manufacturer cards)
• Telehealth bundling (some platforms include the drug in a flat monthly fee)
• Pharmacy choice (chain vs independent vs mail-order)

Insurance Coverage

Most insurance plans cover Ozempic for type 2 diabetes with prior authorization. Coverage for weight loss is rare since Wegovy is the labeled product.

The pattern across the GLP-1 / metabolic medication space is: coverage for diabetes is widespread, coverage for weight loss is improving but still inconsistent, and coverage for any off-label use is rare.

Manufacturer Programs

Novo Nordisk runs savings programs for eligible patients. Eligibility usually requires commercial insurance and an active prescription. Patients on Medicare or Medicaid generally aren't eligible.

Cash-Pay and Direct-from-Manufacturer Options

Several manufacturers have introduced direct-to-consumer cash channels for their GLP-1 products in response to coverage gaps. These can lower the cash price meaningfully — see our guide to getting GLP-1 medications for current options.

Total Cost Over a Year

A monthly price of $950-$1,000/month without insurance translates to roughly $10,800-$18,000 per year out of pocket without insurance. That's a real number to plan around — many programs that look attractive at $200/month for the first three months reset to full price after the introductory window.

For weight management, the relevant question is whether to plan around long-term use; for GLP-1 medications, weight regain after stopping is well-documented.

Comparing to Alternatives

Common alternatives include Mounjaro (tirzepatide, often more weight loss), Trulicity (dulaglutide, also weekly), and Wegovy (same molecule, weight-loss indication). Some of those alternatives may be cheaper, covered when Ozempic isn't, or just better-suited for a particular case. See our cost comparison pages: linked above.

Bottom Line

Don't take the first quoted price as final. Pharmacy choice, savings programs, and direct-pay channels can move the number significantly.

Frequently Asked Questions

Related Reading

• What Is Ozempic? Everything You Should Know Before Starting
• Is Ozempic Safe? An Honest Look at the Side-Effect Profile
• Ozempic Results: Realistic Expectations vs. Trial Headlines
• Getting Ozempic Dosing Right: A Step-by-Step Walkthrough
• Ozempic Before and After: A Week-by-Week Realistic Timeline
• Ozempic Benefits: What the Evidence Actually Supports

Sources

• Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM 2023;389:2221.
• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989.
• Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (SUSTAIN-6). NEJM 2016;375:1834.

Pricing changes frequently. The numbers on this page reflect publicly available information as of 2026-04-29 and should be verified at the point of purchase.